品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

Medchemexpress/Ademetionine(Synonyms: S-Adenosyl-L-methionine; S-Adenosyl methionine; SAMe; AdoMet)/HY-B0617/500mg

价格
¥1400.00
货号:HY-B0617-50mg
浏览量:127
品牌:MCE
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Ademetionine(S-adenosyl-l-methionine; SAMe) is a naturally-occurring substance which is a major source of methyl groups in the brain.
Description

Ademetionine(S-adenosyl-l-methionine; SAMe) is a naturally-occurring substance which is a major source of methyl groups in the brain. Target: Others S-adenosyl-l-methionine (SAMe) is a naturally-occurring substance which is a major source of methyl groups in the brain. The efficacy of SAMe in treating depressive syndromes and disorders is superior with that of placebo and comparable to that of standard tricyclic antidepressants. Since SAMe is a naturally occurring compound with relatively few side-effects, it is a potentially important treatment for depression [1]. S-adenosylmethionine (SAMe) is a dietary supplement used in the management of osteoarthritis (OA) symptoms. Studies evaluating SAMe in the management of OA have been limited to Non Steroidal Anti-inflammatory Drugs (NSAIDs) for comparison. The present study compares the effectiveness of SAMe to a cyclooxygenase-2 (COX-2) inhibitor (celecoxib) for pain control, functional improvement and to decrease side effects in people with osteoarthritis of the knee [2].

Clinical Trial
View MoreCollapse
References
  • [1]. Bressa, G.M., S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl, 1994. 154: p. 7-14.

    [2]. Najm, W.I., et al., S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord, 2004. 5: p. 6.

Preparing Stock Solutions
Concentration Volume Mass 1 mg 5 mg 10 mg
1 mM 2.5098 mL 12.5489 mL 25.0979 mL
5 mM 0.5020 mL 2.5098 mL 5.0196 mL
10 mM 0.2510 mL 1.2549 mL 2.5098 mL
Please refer to the solubility information to select the appropriate solvent.
References
  • [1]. Bressa, G.M., S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl, 1994. 154: p. 7-14.

    [2]. Najm, W.I., et al., S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord, 2004. 5: p. 6.

Molecular Weight

398.44

Formula

C₁₅H₂₂N₆O₅S

CAS No.

29908-03-0

Storage
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
Shipping

Room temperature in continental US; may vary elsewhere

Solvent & Solubility

H2O: ≥ 43 mg/mL; DMSO: ≥100 mg/mL (Need ultrasonic)

* "<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">

Purity: >98.0%

Data Sheet (95 KB) SDS (120 KB)

COA (94 KB) HNMR (189 KB) MS (207 KB)

Handling Instructions (1252 KB)
  • [1]. Bressa, G.M., S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl, 1994. 154: p. 7-14.

    [2]. Najm, W.I., et al., S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord, 2004. 5: p. 6.

他替瑞林口服促甲状腺素释放激素他替瑞林CAS号:103300-74-9英文名称:Taltirelin英文同义词:TA0910;Taltirelin;Taltireline;Ceredist,TA-0910;TaltirelinAcetate;TA-0910,taltirelin;TaltirelininterMediate;TALTIRELININTERMEDIATES;TaltirelinAcetate,TA-0910;L-Prolinamide,(4S)-hexahydro-1-methyl-中文名称:他替瑞林中文同义词:他替瑞林;醋酸他替瑞林;1-METHYL-4,5-DIHYDROOROTYL-HIS-PRO-NH2;(4S)-N-[(2S)-1-[(2S)-2-氨基甲酰基吡咯烷-1-基]-3-(3H-咪唑-4-基)-1-氧代丙-2-基]-1-甲基-2,6-二氧代-1,3-二氮杂己环-4-甲酰胺CBNumber:CB31177191分子式:C17H23N7O5分子量:405.41MOLFile:103300-74-9.mol化学性质安全信息用途供应商86化学性质安全信息用途供应商86他替瑞林化学性质熔点:72-75°比旋光度:25D-13.6°(c=1inwater)密度:1.447±0.06g/cm3(Predicted)储存条件:Storeat+4°C酸度系数(pKa):9.32±0.40(Predicted)安全信息他替瑞林性质、用途与生产工艺口服促甲状腺素释Chemicalbook放激素他替瑞林是一种垂体激素释放兴奋药,由日本田边三菱制药株式会社研制成功,商品名Taltirelin,属于化药新药3.1类,目前临床用于改善脊髓小脑变性患者的运动失调最为有效的药物。他替瑞林(Taltirelin)是世界上第一个批准的口服促甲状腺素释放激素(TRH),除具有内分泌作用外,还可发挥一定的中枢神经系统(CNS)作用,包括提高运动活性,拮抗利舍平诱导的体温降低,以及拮抗戊巴比妥诱导的睡眠。该品种由日本田边三菱制药株式会社开发,2000年9月首次在日本上市,用于改善脊髓小脑变性病人的共济失调。脊髓小脑共济失调(SCAs)旧称常染色体显性共济失调,是一组以共济失调、辨距不良为主要临床表现的中枢神经系统慢性变性疾病。2000年9月前,促甲状腺素释放激素(TRH)注射液是唯一用于治疗该类疾病的药物。他替瑞林是TRH的结构修饰改造药物,药理学研究显示本品经由脑TRH受体对CNS产生强而持久的多重作用。本品对CNS的兴奋作用比TRH强10~100倍,作用持续时间比TRH长约8倍。本品对TRH受体的亲和力约为TRH的1/11,因而本品的内分泌作用比TRH弱,但本品在体内比TRH稳定。另外本品对促甲状腺素(TSH)释放的作用为TRH的1/6-1/11,TSH释放是由一个包括甲状腺激素的强负反馈系统调节的,对中枢神经系统具有较强的作用,但同时其激素样作用较小,因此副作用较少。不良反应主要是消化系统反应,包括呕吐、恶心和胃不适。所有的不良反应均为轻中度,在治疗期间及(或)停药后消失。